[go: up one dir, main page]

PL3006427T3 - Fluorowany związek estru kwasu benzilowego i jego sole - Google Patents

Fluorowany związek estru kwasu benzilowego i jego sole

Info

Publication number
PL3006427T3
PL3006427T3 PL14804112T PL14804112T PL3006427T3 PL 3006427 T3 PL3006427 T3 PL 3006427T3 PL 14804112 T PL14804112 T PL 14804112T PL 14804112 T PL14804112 T PL 14804112T PL 3006427 T3 PL3006427 T3 PL 3006427T3
Authority
PL
Poland
Prior art keywords
salt
acid ester
ester compound
benzilic acid
fluorinated
Prior art date
Application number
PL14804112T
Other languages
English (en)
Inventor
Masato Nanri
Kazuharu Noguchi
Fukumitsu Sakakibara
Shinichi Aoki
Original Assignee
Taiho Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co., Ltd. filed Critical Taiho Pharmaceutical Co., Ltd.
Publication of PL3006427T3 publication Critical patent/PL3006427T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4465Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
PL14804112T 2013-05-30 2014-05-29 Fluorowany związek estru kwasu benzilowego i jego sole PL3006427T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013114142 2013-05-30
PCT/JP2014/064216 WO2014192847A1 (ja) 2013-05-30 2014-05-29 新規なフッ素化ベンジル酸エステル化合物又はその塩
EP14804112.2A EP3006427B1 (en) 2013-05-30 2014-05-29 Fluorinated benzilic acid ester compound and salt thereof

Publications (1)

Publication Number Publication Date
PL3006427T3 true PL3006427T3 (pl) 2018-03-30

Family

ID=51988870

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14804112T PL3006427T3 (pl) 2013-05-30 2014-05-29 Fluorowany związek estru kwasu benzilowego i jego sole

Country Status (16)

Country Link
US (1) US9718776B2 (pl)
EP (1) EP3006427B1 (pl)
JP (1) JP6045691B2 (pl)
KR (1) KR101745814B1 (pl)
CN (1) CN105283444B (pl)
AU (1) AU2014271739B2 (pl)
CA (1) CA2914147C (pl)
ES (1) ES2652555T3 (pl)
MX (1) MX2015016310A (pl)
MY (1) MY181470A (pl)
PH (1) PH12015502498B1 (pl)
PL (1) PL3006427T3 (pl)
RU (1) RU2632881C2 (pl)
SG (1) SG11201508840RA (pl)
TW (1) TWI571459B (pl)
WO (1) WO2014192847A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD139212A1 (de) * 1978-10-09 1979-12-19 Christian Starke Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten
JPH0611758B2 (ja) 1985-08-14 1994-02-16 大鵬薬品工業株式会社 ベンジル酸−4−ピペリジルエステル誘導体
JPH0669068B2 (ja) 1985-08-30 1994-08-31 株式会社東芝 多層配線の製造方法
JP2549183B2 (ja) * 1990-02-26 1996-10-30 三共株式会社 アクリル酸ピペリジルエステル誘導体の製法
DE10129832A1 (de) * 2001-06-17 2003-07-10 Berolina Drug Dev Ab Svedala Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
CA2914147C (en) 2018-08-14
SG11201508840RA (en) 2015-11-27
HK1217332A1 (zh) 2017-01-06
EP3006427B1 (en) 2017-11-15
TW201533026A (zh) 2015-09-01
PH12015502498A1 (en) 2016-02-22
RU2015156609A (ru) 2017-07-06
WO2014192847A1 (ja) 2014-12-04
PH12015502498B1 (en) 2016-02-22
BR112015029251A2 (pt) 2017-07-25
CA2914147A1 (en) 2014-12-04
ES2652555T3 (es) 2018-02-05
EP3006427A4 (en) 2017-01-11
KR101745814B1 (ko) 2017-06-12
MY181470A (en) 2020-12-22
US20160115129A1 (en) 2016-04-28
AU2014271739A1 (en) 2015-12-03
CN105283444B (zh) 2017-06-16
KR20160013148A (ko) 2016-02-03
JP6045691B2 (ja) 2016-12-14
US9718776B2 (en) 2017-08-01
TWI571459B (zh) 2017-02-21
EP3006427A1 (en) 2016-04-13
MX2015016310A (es) 2016-03-03
JPWO2014192847A1 (ja) 2017-02-23
CN105283444A (zh) 2016-01-27
AU2014271739B2 (en) 2016-07-28
RU2632881C2 (ru) 2017-10-11

Similar Documents

Publication Publication Date Title
ZA201805629B (en) Leucine and nicotinic acid reduces lipid levels
IL274454A (en) Hyaluronic acid preparations including mepivacaine
PL2997117T3 (pl) Zastosowanie estru
RU2016118399A3 (en) 4-aminomethylbenzoic acid derivative
ME03398B (me) Spojevi dimetilbenzojeve kiseline
SG11201508542SA (en) Dicarboxylic acid compound
SI2975022T1 (sl) Novi derivati hidroksamske kisline ali soli le-teh
ZA201506745B (en) Guanidinobenzoic acid ester compound
IL246230A0 (en) Amines thf quinazoline as pde1 inhibitors
PL3006427T3 (pl) Fluorowany związek estru kwasu benzilowego i jego sole
EP3000807A4 (en) Mercaptonicotinic acid compound and preparation method and use thereof
EP2984062A4 (en) HYDROLYSIS OF AN ESTER COMPOUND
GB201402985D0 (en) Active tagging
AU2013072V (en) Pink Frost Illicium floridanum